GB201311036D0 - Biomarkers for alzheimer's Disease - Google Patents

Biomarkers for alzheimer's Disease

Info

Publication number
GB201311036D0
GB201311036D0 GB201311036A GB201311036A GB201311036D0 GB 201311036 D0 GB201311036 D0 GB 201311036D0 GB 201311036 A GB201311036 A GB 201311036A GB 201311036 A GB201311036 A GB 201311036A GB 201311036 D0 GB201311036 D0 GB 201311036D0
Authority
GB
United Kingdom
Prior art keywords
biomarkers
alzheimer
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB201311036A
Other versions
GB2515334A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuro Bio Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GB201311036A priority Critical patent/GB2515334A/en
Publication of GB201311036D0 publication Critical patent/GB201311036D0/en
Priority to PCT/GB2014/051820 priority patent/WO2014202955A1/en
Publication of GB2515334A publication Critical patent/GB2515334A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
GB201311036A 2013-06-20 2013-06-20 Biomarkers for alzheimer's Disease Withdrawn GB2515334A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201311036A GB2515334A (en) 2013-06-20 2013-06-20 Biomarkers for alzheimer's Disease
PCT/GB2014/051820 WO2014202955A1 (en) 2013-06-20 2014-06-13 Biomarkers for alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201311036A GB2515334A (en) 2013-06-20 2013-06-20 Biomarkers for alzheimer's Disease

Publications (2)

Publication Number Publication Date
GB201311036D0 true GB201311036D0 (en) 2013-08-07
GB2515334A GB2515334A (en) 2014-12-24

Family

ID=48950225

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201311036A Withdrawn GB2515334A (en) 2013-06-20 2013-06-20 Biomarkers for alzheimer's Disease

Country Status (2)

Country Link
GB (1) GB2515334A (en)
WO (1) WO2014202955A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2663451C1 (en) * 2017-09-28 2018-08-06 Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья" Method for predicting the likelihood of developing alzheimer's disease (ad)
JP7457300B2 (en) * 2018-08-29 2024-03-28 国立大学法人 岡山大学 Peptide markers for diagnosis of neurodegenerative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164668A1 (en) * 2000-04-03 2002-11-07 Durham L. Kathryn Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
DE10158180A1 (en) * 2001-11-28 2003-09-11 Biovision Ag Method for the detection of Alzheimer's disease and to differentiate Alzheimer's disease from other dementia diseases, associated peptides and their use
SG115540A1 (en) * 2003-05-17 2005-10-28 St Microelectronics Asia An edge enhancement process and system
US7268117B2 (en) * 2003-07-11 2007-09-11 Praecis Pharmaceuticals Incorporated Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis
WO2007022248A2 (en) * 2005-08-16 2007-02-22 Sloan Kettering Institute For Cancer Research Methods of detection of cancer using peptide profiles
WO2008105215A1 (en) * 2007-02-28 2008-09-04 Nitto Boseki Co., Ltd. Marker peptide for diagnosis of alcoholic liver disease, and method for diagnosis of alcoholic liver disease using the same
WO2013059234A1 (en) * 2011-10-18 2013-04-25 Metabolon, Inc. Biomarkers for amyotrophic lateral sclerosis and methods using the same

Also Published As

Publication number Publication date
GB2515334A (en) 2014-12-24
WO2014202955A1 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
IL279359A (en) Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders
GB201206382D0 (en) Parkinson's disease biomarker
GB201311036D0 (en) Biomarkers for alzheimer's Disease
GB201316131D0 (en) Biomarkers for disease stratification
GB201414038D0 (en) Alzheimer's disease
GB201308820D0 (en) Part 3 under
GB201303232D0 (en) Tramadol for the mouth
GB201322568D0 (en) Taggstar 1
GB201310407D0 (en) Plantladders 3
GB201310285D0 (en) Twist-Away 270
GB201311350D0 (en) Step 2
GB201319403D0 (en) Concept 77
GB201311558D0 (en) Concept 23
GB201311540D0 (en) Concept 72
GB201311530D0 (en) Concept 46
GB201311488D0 (en) Concept 51
GB201311489D0 (en) Concept 52
GB201311469D0 (en) Concept 12 12
GB201311483D0 (en) Concept 48
GB201311564D0 (en) Concept 33
GB201311490D0 (en) Concept 53
GB201311557D0 (en) Concept 65
GB201311556D0 (en) Concept 61
GB201311555D0 (en) Concept 60
GB201311554D0 (en) Concept 74

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: NEURO-BIO LTD

Free format text: FORMER OWNER: ISIS INNOVATION LIMITED

WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)